Platinol-AQ Alternatives Compared
Platinol-AQ | Nivolumab | Tagrisso |
|
---|
Platinol-AQ (cisplatin) | Nivolumab | Tagrisso (osimertinib) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Bladder Cancer, Bone Marrow Transplantation, Blood Cell Transplantation, Brain Tumor, Cervical Cancer, Neuroblastoma, Non Small Cell Lung Cancer, Osteogenic Sarcoma, Ovarian Cancer... View more |
Prescription only
Prescribed for Esophageal Carcinoma, Head and Neck Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Hodgkin's Lymphoma, Malignant Pleural Mesothelioma, Melanoma, Melanoma - Metastatic, Non Small... View more |
Prescription only
Prescribed for Non Small Cell Lung Cancer. Tagrisso may also be used for purposes not listed in this medication guide. |
||||||||
More about Platinol-AQ (cisplatin) | More about Nivolumab | More about Tagrisso (osimertinib) | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Nivolumab has an average rating of 5.4 out of 10 from a total of 125 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 46% reported a negative effect. |
Tagrisso has an average rating of 7.3 out of 10 from a total of 36 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 25% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Platinol-AQ side effects in more detail. |
See also: nivolumab side effects in more detail. |
See also: Tagrisso side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Tagrisso prices |
||||||||
Dosage Forms Available | ||||||||||
N/A |
N/A |
|
||||||||
Brand Names | ||||||||||
N/A |
Opdivo |
N/A |
||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
73 hours |
640.8 hours |
48 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 442 drugs are known to interact with Platinol-AQ:
|
A total of 16 drugs are known to interact with nivolumab:
|
A total of 584 drugs are known to interact with Tagrisso:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
December 22, 2014 |
November 13, 2015 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
N/A |
||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.